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Background: Infectious intestinal disease (IID) is a major health and economic burden in high-income countries. In
the UK, there are an estimated 17 million IID cases annually, of which 6 million are caused by the 12 most common
pathogens. Host factors that influence risk of IID are not well understood.
Methods: We analyzed data from the IID2 Study, a UK cohort that measured IID incidence, to investigate factors
associated with recurrent IID. We calculated rates of IID by age group, sex, previous episodes experienced, and
socioecomic indicators. We used Cox models to investigate factors associated with recurrent illness.
Results: The rate of IID was five times higher among infants than those aged 65 years and above (hazard ratio, HR = 5.0,
95% CI: 3.1 – 8.0). However, the association between previous IID and a subsequent IID episode was stronger in the
elderly. Among those aged 65 years and above, each additional IID episode increased the rate of subsequent IID
three-fold (HR = 3.1, 95% CI: 2.5 – 3.7). Among infants, the corresponding increase was 1.7-fold (HR = 1.7, 95% CI: 1.3 – 2.3).
Conclusions: Elderly populations have a high propensity for recurrent IID. More detailed studies are needed to identify
vulnerable subgroups and susceptibility factors, and inform adequate control policies among the elderly.
Keywords: Diarrhoea, Diarrhoeal diseases, Infectious intestinal disease, Enteric pathogens, Elderly populations,
Cohort studiesBackground
Infectious intestinal disease (IID) is a syndrome characterised
by symptoms of diarrhoea and/or vomiting, often accom-
panied by additional symptoms including fever and ab-
dominal pain. It is caused by a wide range of pathogens
or their associated toxins, and infection with these agents
commonly results from the ingestion of contaminated
foods, through the faeco-oral route, or from zoonotic
transmission. Disease is generally mild and of short dur-
ation, but can result in severe illness, hospitalisation and
even death, while some pathogens are associated with long-
term sequelae, including haemolytic uraemic syndrome,
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reproduction in any medium, provided the orIID is a major cause of morbidity in high-income coun-
tries. In the UK, the incidence of IID was recently estimated
in the Second Study of Infectious Intestinal Disease (IID2),
a prospective study to measure the rate and microbial aeti-
ology of IID occurring in the general population, presenting
to primary care, and reported to national surveillance. In
that study, the incidence of all-cause IID was estimated at
274 cases per 1000 person-years, equating to approximately
17 million cases and 1 million general practice (GP)
consultations each year [1]; among thosed aged 65 years
and above, the estimated rate was 195 cases per 1000
person-years (95% CI: 173 – 220) [2]. In two large national
studies conducted in Australia in 2001 and 2008 to deter-
mine incidence and outcomes of gastroenteritis in people
aged over 65 years, the estimated rate of illness was 330
episodes of gastroenteritis per 1,000 person years (95%
confidence interval (CI): 240 – 420) [3]. In England and
Wales, more than 60,000 laboratory-confirmed campylo-
bacteriosis cases are reported each year; persons over 65. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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percentages are 11% for salmonellosis, 55% for listeriosis
and 72% for norovirus IID, the latter resulting primarily
from outbreaks in institutions and healthcare settings [4].
In addition, Clostridium difficile is one of the most com-
monly studied causes of gastroenteritis in the elderly. Mor-
bidity and mortality associated with Clostridium difficile
infection is an important problem among vulnerable
and elderly hospitalised populations [5], although data
on community carriage levels, i.e. in people residing at
home and not in long term care facilities, are scarce. In
the IID2 Study, this pathogen did not feature among the
causative agents of IID in a general population cohort,
and was responsible for 0.1% of cases presenting to gen-
eral practice [6]. In one study in Merseyside, England,
4% of healthy elderly patients living at home were found
to be excreting C. difficile. All were symptom free [7].
In recent years, there have been major changes in
the epidemiology of infectious intestinal and foodborne
diseases in the elderly, including campylobacteriosis [8]
and listeriosis [9]. Indeed, the incidence of several major
pathogens reported to national surveillance systems has
increased in people over the age of 60 years. What is not
always clear from analyses of routine national surveillance
data, which are often anonymised, is whether or not
the increased incidence represents more people affected
overall or an increase in people with repeat infections.
The former might indicate that exposure to foodborne
pathogens has changed whilst the latter might indicate an
increase in susceptibility amongst a more limited pool of
people. Few longitudinal studies have been conducted in
high-income countries [1,10,11] and to our knowledge
none have characterized recurrent IID in older age groups.
The IID2 Study presented a unique opportunity to deter-
mine the extent to which repeat infections occur in elderly
people. We conducted a secondary analysis of data from
the recent IID2 Study in the UK to compare the character-
istics of individuals reporting one and more than one
episode of IID, and investigate whether the number
of previous IID episodes reported influences the subse-
quent rate of IID in different age groups.
Methods
The IID2 Study has been described in detail elsewhere
[6,12]. Briefly, the study included a population cohort
consisting of 6836 participants of all ages recruited from
the registered population of 88 general practices in the
UK. Individuals with known, chronic causes of diarrhoea
were excluded, as were those with terminal illness, severe
mental impairment and non-English speakers for whom a
suitable interpreter could not be identified. Participants
were followed up weekly for symptoms of diarrhoea
and/or vomiting for a period of up to 52 weeks between
October 2007 and August 2009. Symptomatic individualswere asked to complete a questionnaire with details of
clinical characteristics of disease and healthcare usage and
to submit a stool specimen for microbiological examin-
ation. A case of IID was defined as loose stools or clinic-
ally significant vomiting lasting less than 2 weeks, in the
absence of a known non-infectious cause, preceded by a
symptom-free period of 3 weeks. Vomiting was clinically
significant if it occurred more than once in a 24 h period
and if it incapacitated the patient or was accompanied by
other symptoms such as cramps or fever [1]. The study
was granted a favourable ethics opinion by the NHS
North West Research Ethics Committee (07/MRE08/5),
and was approved by 37 NHS Research Management
and Governance organisations for the general practices
involved.
Participants were followed up for a median of 39 weeks
(inter-quartile range: 27 – 45 weeks). The rate of UK-
acquired IID, standardized to the age and sex distribution
of the UK population, was 274 cases per 1000 person-
years (95% CI: 254 to 296).
For the present analysis, we investigated the frequency
of recurrent IID, whether recurrent IID clustered in
certain groups of individuals, and whether a previous
episode of IID was associated with a higher incidence
of recurrent episodes. We included in the analysis both
UK-acquired and travel-related episodes meeting the
above case definition for IID.
Analysis
Characteristics of participants with no episodes, single
episodes and multiple episodes of IID
We compared participants who did not report any epi-
sodes of IID throughout their follow-up period with par-
ticipants who reported one and more than one episode.
We compared these three groups in terms of age distri-
bution, sex, socioeconomic classification, and area-level
deprivation and urban rural classification based on their
postcode of residence. Age was categorized into five
strata: <1 year, one to four years, five to 14 years, 15 to
64 years, and 65+ years. Although these groupings are
coarse, we did not find substantial differences in IID
incidence beyond the age of five years in our study [2].
We measured socioeconomic classification using the
National Statistics – Socioeconomic Classification (NS-SEC)
[13]. We used the χ2 test and associated p-value to iden-
tify potentially important differences in these factors
between groups.
Rates of IID
Since participants were followed up for varying lengths
of time, we next calculated rates of IID, with associated
95% confidence intervals (95% CIs), by strata of the
above factors, taking into account individuals’ length
of follow-up. In addition, we calculated rates of IID
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pants had experienced.Effect of previous episodes on rate of recurrent IID
We then investigated whether a prior episode of IID
was associated with an increased rate of IID using Cox
regression modelling. We used a counting process ap-
proach as recommended by Guo et al. [14]. In this
approach, each participant contributes to the person-
time of observation, and can contribute multiple IID
episodes, for as long as they are at risk and remain in
the study. Our case definition stipulated that disease had
to last <14 days and should be preceded by a symptom-
free period of at least three weeks. Thus, participants were
considered at-risk from the fourth week of follow-up (pro-
vided they had been symptom-free since enrolment) until
their first episode. They were considered not at-risk for
the duration of their illness and for a further three weeks,
at which point they returned to the at-risk pool. Weeks
with missing responses were assumed to be non-informative
(that is, the incidence of IID on these weeks was the same
as on observed weeks), but individuals were censored for
the duration of non-response and a further three weeks
thereafter. Participants with symptoms of 14+ days dur-
ation were not included as IID cases, and were censored
until three weeks after cessation of symptoms.
Participants could therefore contribute multiple spells
of follow-up, each ending either in exit from the study
(due to end of follow-up, end of the study, or loss to
follow-up), an episode of IID, or censoring (due to non-
response, or symptoms not meeting the case definition).
For each spell of follow-up, we created a variable denoting
how many previous IID episodes the participant had expe-
rienced, and included this as the independent variable of
interest in our Cox model. We constructed a multivariable
regression model using a forward stepwise approach. We
adjusted in turn for age group, sex, NS-SEC, area-level
deprivation and urban–rural classification. We looked for
evidence of confounding by each of these factors by
assessing their effect on estimates of the hazard ratio
(HR) for the association between previous episodes and
IID rates, and assessed their contribution to the model
using the likelihood ratio (LR) test. Factors that resulted
in a considerable change in the HR (>10%), or that
resulted in a low LR test p-value (<0.05), were retained
as covariates in the model. We additionally tested for
evidence of a linear effect of the number of previous
episodes on IID incidence. For this, we used the LR
test to compare a model including indicators for the
number of previous episodes with one including a single
linear term, and opted for the model with the best fit.
Finally, we investigated whether the effect of previous
episodes on IID incidence was influenced by age group,by comparing models with and without an interaction
term between these two variables using the LR test.
A complication of multiple-event data is the dependence
of observations within individuals. This dependence is
partly accounted for by the inclusion of number of previ-
ous episodes as a covariate in the model, as individuals
with recurrent episodes must, by definition, have experi-
enced at least one previous episode. However, because
the LR test does not adequately deal with this depend-
ence, we repeated the model selection process using
robust standard errors and favouring models with lower
values of the Akaike Information Criterion (AIC). Both
model selection procedures resulted in the same final
model.
Sensitivity analysis
Incidence in the cohort decreased with time in study [2].
For this reason, we conducted a sensitivity analysis by
sequentially excluding from our final model individuals
with varying lengths of follow-up to determine whether
this influenced the model coefficients.
Analysis was conducted using Stata 12.1 (Statacorp,
Texas).
Results
Characteristics of participants with no episodes, single
episodes and multiple episodes of IID
Among the 6836 participants, a total of 1320 IID cases
occurred in 4658.6 person-years of follow-up. Nine hundred
and one participants reported one episode of IID and 189
reported more than one. Infants and children under five
years were more likely than older age groups to report
at least one episode of IID (p < 0.001); 21% of infants
experienced more than one IID episode (Table 1). Dif-
ferences were seen for other factors, but no clear pat-
terns emerged.
Rates of IID
The overall rate of IID was 283.4 cases per 1000 person-
years (95% CI: 268.5 - 299.1). The rate increased from
254.7 cases per 1000 person-years (95% CI: 240.0 - 270.3)
among those with no previous IID episodes to 980.2 per
1000 person-years (95% CI: 719.0 - 1,336.3) among those
with two previous episodes. Participants who experienced
three or more previous episodes had even higher rates,
although there were very few cases in these categories.
IID incidence was also higher among infants and children
under five years and females. Some differences were
also observed between categories of NS-SEC, area-level
deprivation and urban–rural classification (Table 2).
Effect of previous episodes on recurrent IID
The final model included age group, a linear term for
the number of previous episodes, and their interaction,




Variable No. % No % No % χ2 p
Age group
<1 year 24 57.1% 9 21.4% 9 21.4% 180.20 <0.001
1 to 4 years 182 62.5% 86 29.6% 23 7.9%
5 to 14 years 517 82.9% 90 14.4% 17 2.7%
15 to 64 years 3,357 84.5% 518 13.0% 99 2.5%
65+ years 1,666 87.5% 198 10.4% 41 2.2%
Sex
Male 2,307 86.2% 300 11.2% 69 2.6% 15.92 <0.001
Female 3,439 82.7% 601 14.4% 120 2.9%
NS-SEC1
Managerial and professional occupations 2,938 82.6% 514 14.5% 105 3.0% 30.32 0.001
Intermediate occupations 256 83.1% 47 15.3% 5 1.6%
Small employers and own account workers 574 82.7% 96 13.8% 24 3.5%
Lower supervisory and technical occupations 620 89.5% 63 9.1% 10 1.4%
Semi-routine and routine occupations 408 86.4% 53 11.2% 11 2.3%
Not classifiable 950 85.4% 128 11.5% 34 3.1%
Quintile of deprivation2
1 (most deprived) 420 87.1% 49 10.2% 13 2.7% 12.48 0.131
2 644 86.2% 80 10.7% 23 3.1%
3 1,515 83.3% 247 13.6% 56 3.1%
4 1,798 83.9% 286 13.4% 58 2.7%
5 (least deprived) 1,366 83.1% 239 14.5% 39 2.4%
Urban/rural indicator2
Urban 3,445 84.5% 514 12.6% 116 2.8% 15.06 0.005
Town 766 86.3% 96 10.8% 26 2.9%
Rural 1,532 81.9% 291 15.6% 47 2.5%
1 National-Statistics Socioeconomic Classification; 2 3 missing values.
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term was well supported by the LR test (p < 0.001), and
this model gave the lowest AIC of all candidate models
evaluated.
Among those with no previous episodes, infants had
the highest rate of IID, five times higher than those aged
65+ years (HR = 5.0, 95% CI: 3.11 - 8.03) (Table 3). Among
infants with at least one episode, each additional episode
increased the rate of recurrent IID by 1.7 times on average
(HR = 1.6, 95% CI: 1.25 – 2.32). By contrast, the elderly
had the lowest rates of disease overall, but each additional
episode resulted in a three-fold increase in the incidence
of a subsequent episode (HR = 3.08, 95% CI: 2.54 - 3.74).
The corresponding HRs were 2.49 among five to 14 year-
olds, and 2.08 among 15 to 64 year-olds. Among one to
five year-olds, there was very weak evidence for an effectof previous episodes on recurrent IID (HR = 1.49, 95% CI:
0.95 - 1.72).
Sensitivity analysis
In the sensitivity analysis, excluding individuals with
fewer than 27 weeks of follow-up had little effect on the
results (Figure 1). When only individuals with >39 weeks
of follow-up were included in the model, the effect of
previous episodes on IID rate was markedly decreased in
all age groups, although the main effect for age remained
unchanged. This was likely the result of a loss of statis-
tical power to investigate interaction effects, as there
were no individuals with more than two episodes among
those with >39 weeks of follow-up. The effect of previ-
ous episodes among the 65+ age group, however, was
still apparent.
Table 2 Rates of IID in the community by age group, sex, socioeconomic and geographic factors, and number of
previous IID episodes, IID2 Study, UK 2008-9
Stratum Cases PY Rate (95% CI)
All 1,320 4,658.6 283.4 (268.5 - 299.1)
Age group
<1 year 33 26.9 1,228.3 (873.2 - 1,727.7)
1 to 4 years 138 190.8 723.4 (612.2 - 854.7)
5 to 14 years 129 424.1 304.2 (256.0 - 361.5)
15 to 64 years 728 2,647.8 274.9 (255.7 - 295.7)
65+ years 292 1,369.1 213.3 (190.2 - 239.2)
Sex
Male 459 1,840.6 249.4 (227.6 - 273.3)
Female 861 2,818.0 305.5 (285.8 - 326.6)
Number of previous episodes
0 1,086 4,300.0 254.7 (240.0 - 270.3)
1 186 349.6 532.1 (460.9 - 614.3)
2 40 40.8 980.2 (719.0 - 1,336.3)
3 7 4.1 1,710.2 (815.3 - 3,587.3)
4 1 0.1 7,305.0 (1,029.0 - 51,858.7)
Deprivation quintile
1 (most deprived) 76 328.9 231.1 (184.5 - 289.3)
2 134 509.5 263.0 (222.1 - 311.6)
3 377 1,232.6 305.9 (276.5 - 338.3)
4 411 1,485.5 276.7 (251.2 - 304.8)
5 (least deprived) 322 1,100.4 292.6 (262.3 - 326.4)
NS-SEC1
Managerial and professional occupations 749 2,418.3 309.7 (288.3 - 332.7)
Intermediate occupations 58 202.8 286.0 (221.1 - 370.0)
Small employers and own account workers 148 473.6 312.5 (266.0 - 367.1)
Lower supervisory and technical occupations 83 459.2 180.8 (145.8 - 224.2)
Semi-routine and routine occupations 78 320.6 243.3 (194.9 - 303.7)
Not classifiable 204 784.2 260.1 (226.8 - 298.4)
Urban–rural classification
Urban 765 2,778.1 275.4 (256.5 - 295.6)
Town 158 580.2 272.3 (233.0 - 318.3)
Rural 397 1,298.6 305.7 (277.1 - 337.3)
1 National-Statistics Socioeconomic Classification.
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Our results provide evidence that the rate of IID recur-
rence varies by age. Although infants experience more
episodes of IID, among older age groups recurrent IID
clusters much more strongly in certain individuals. This
effect was particularly pronounced in the elderly, in
whom every additional IID episode increased the rate
of a subsequent episode by three times. We are not
aware of previous evidence from observational studies
for such strong clustering effects in adult age groups. Inan analysis of surveillance data on laboratory-confirmed
campylobacteriosis in Québec, Canada, Arsenault et al.
found that, over a period of 11 years, a second episode
of Campylobacter IID was more likely to be reported
among those aged 15 years and above compared with
children under 5 years [15].
While our data demonstrate an age-dependent effect
of recurrent IID, we have no direct evidence for the bio-
logical mechanisms involved. However, it is possible that
this effect results from changes in immune development
Table 3 Factors associated with IID incidence in the community, IID2 Study, UK 2008–9
Variable RR p (95% CI)1
Age group
<1 year-olds 5.00 <0.001 (3.11 - 8.03)
1 to 4 year-olds 3.62 <0.001 (2.91 - 4.52)
5 to 14 year-olds 1.40 0.003 (1.12 - 1.76)
15 to 64 year-olds 1.27 0.002 (1.09 - 1.48)
65+ year-olds 1.00 – –
Linear effect of previous episodes on:
<1 year-olds 1.70 0.001 (1.25 - 2.32)
1 to 4 year-olds 1.28 0.109 (0.95 - 1.72)
5 to 14 year-olds 2.49 <0.001 (1.78 - 3.47)
15 to 64 year-olds 2.08 <0.001 (1.80 - 2.41)
65+ year-olds 3.08 <0.001 (2.54 - 3.74)
Sex
Male 1.00 – –
Female 1.22 0.001 (1.08 - 1.37)
NS-SEC
Managerial and professional occupations 1.00 – –
Intermediate occupations 0.96 0.772 (0.74 - 1.25)
Small employers and own account workers 0.98 0.843 (0.82 - 1.17)
Lower supervisory and technical occupations 0.63 <0.001 (0.51 - 0.80)
Semi-routine and routine occupations 0.82 0.089 (0.64 - 1.03)
Not classifiable 0.90 0.189 (0.76 - 1.05)
195% CIs are based on robust standard errors.
Results from a multivariable Cox regression model.
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gens, rates of disease are highest in infants and decrease
markedly with age. In particular, rotavirus is the third
most common pathogen among paediatric IID cases [6],
accounting for a sixth of cases in children under five
years in the IID2 Study for whom an aetiological agent
could be identified. Infection with rotavirus is known to
decrease the risk of clinical disease following subsequent
rotavirus infection [16,17]; by the age of five, most infec-
tions are asymptomatic. This would partly account for
the decreased effect of previous episodes on recurrent
disease in young children compared with other age
groups. Infection with norovirus and sapovirus, the two
commonest pathogens in this age group, results in short-
term protection from re-infection with related strains, and
could also explain the lower rate of recurrent disease in
young children compared with older age groups over the
relatively short follow-up period of our study.
Among older individuals, the increased rate of recurrent
IID is likely due to a greater proportion of individuals with
impaired immune function, or chronic or transient
gastrointestinal conditions that increase susceptibility to
infection with enteric pathogens. Alternatively, infectionat older age groups could result in long-lasting changes
to the gut flora that facilitate subsequent infection. In
our study, we excluded individuals with known chronic
gastrointestinal conditions, but it is possible that a fraction
of individuals had undiagnosed bowel abnormalities. We
did not have information on other conditions that affect
immune function, such as diabetes and HIV, or on the use
of medications that could influence susceptibility to infec-
tion, such as use of steroids, antibiotics, or proton pump
inhibitors.
An alternative explanation for the higher rates of re-
current IID in older age groups is that enteric infections
themselves increase the risk of bowel abnormalities;
irritable bowel syndrome is commonly reported following
infection with Campylobacter and other bacterial patho-
gens [18,19]. This could suggest that infection with specific
pathogens might lead to subsequent diarrhoea episodes
in which no pathogen can be found. Our study was in-
sufficiently powered to investigate the effect of specific
pathogens on subsequent IID episodes; 60% of speci-
mens in the IID2 Study were negative for any of the
pathogens investigated [6], and the number of recurrent
episodes was relatively small. However, we defined a
Figure 1 Sensitivity analysis investigating the influence of varying lengths of follow-up on model-estimated hazard ratios and 95% CIs
for the main effects of age and the interaction between age group and a linear effect of previous episodes. Dark squares: all cohort
participants; Light squares: participants with >12 weeks of follow-up; Dark circles: participants with >26 weeks of follow-up; Light circles:
participants with >39 weeks of follow-up.
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week symptom-free period, and our case definition ex-
cluded episodes of diarrhoea lasting more than 14 days. It
is therefore unlikely that these recurrent episodes consti-
tuted persistent or pre-existing bowel abnormalities.
Ascertainment of diarrhoea cases in the IID2 Study re-
lied on weekly, active follow-up of individuals and in-
cluded negative reporting of symptoms. Nevertheless, it
is possible that completeness of reporting, or the effects
of reporting fatigue, differed between age groups. This
could partly explain our results if reporting of symptoms
was more complete in older age groups, but decreased
over the follow-up period among younger individuals.
In our data, this would manifest itself as a change in the
relative rate of disease between different age groups
over time, effectively a violation of the proportional haz-
ards assumption required by the Cox model. We found
no evidence of a violation of this assumption, and we
think this explanation is unlikely.
A further limitation of our study is that we only had
information on IID symptoms during the follow-up period.
Our data on previous IID episodes is therefore limited to
the period of observation. This is likely to underestimateindividuals’ IID experience and would tend to limit our
ability to observe an effect on recurrent IID, although it is
unlikely to have resulted in spurious associations.
Our study indicates that certain subgroups in the
population have a high propensity for recurrent IID,
particularly among older age groups. The mechanisms
for this are unclear, but prevention and control of IID is
likely to require a better understanding of how under-
lying conditions affect both the risk and the outcomes
of IID, especially among the elderly. More detailed stud-
ies among vulnerable populations, including those with
underlying conditions or impaired immunity, should
help to better establish the risks and pathogens associ-
ated with certain subgroups and inform adequate con-
trol policies. Clinicians should be aware of the increased
risk of recurrent IID among the elderly and consider
whether closer monitoring is required, particularly in the
context of underlying conditions. Diarrhoea is a common
condition in the elderly that can have profound conse-
quences either owing to the effects of the causative organ-
ism itself or because of the associated dehydration [20,21].
C. difficile is considered to be the most likely cause of
persistent or relapsing diarrhoea in the elderly, but our
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an elderly population in which C. difficile was rare. With
the advent of molecular methods that can be used to
screen for multiple pathogens at the same time it is pos-
sible that the diversity of organisms causing recurrent
gastroenteritis in the elderly will be better understood.
This, in turn, might mean that unnecessary antibiotic
treatment or invasive procedures can be avoided.
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